Evidence map›Paper›PMID 33435894›Full record

ArticleBMC infectious diseases2021

The diagnostic value of metagenomic next⁃generation sequencing in infectious diseases.

Hongxia Duan, Xuan Li, Aihong Mei, Ping Li, Yang Liu, Xiaofeng Li, Weiwei Li, Changhui Wang, Shuanshuan Xie

Open access · goldAbstract readComparative Study
In one paragraph

Article in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 124 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed, 2 pooled it
13.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

124 citing papers in PubMed, 2 syntheses or guidelines pooled it, 187 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Polygonum cuspidatum Exosome-Like Nanovesicles Alleviate Hypoxic Pulmonary Hypertension by Stabilizing PON1 to Inhibit MAPK-Mediated PASMC Phenotypic Switching.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. The relationship betweenFrontiers in medicine · 2026
    Article
  10. Article
  11. Article
  12. Metagenomic next-generation sequencing: new horizons in microbiology.Frontiers in cellular and infection microbiology · 2026
    Review
  13. Article
  14. ChronicInfection and drug resistance · 2026
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Hongxia DuanDepartment of Respiratory Medicine, Shanghai 10th People's Hospital, Tongji University School of Medicine, #301, Mid Yanchang Rd, Shanghai, 200072, China.
Xuan LiDepartment of Respiratory Medicine, Shanghai 10th People's Hospital, Tongji University School of Medicine, #301, Mid Yanchang Rd, Shanghai, 200072, China.
Aihong MeiDepartment of Respiratory Medicine, Shanghai 10th People's Hospital, Tongji University School of Medicine, #301, Mid Yanchang Rd, Shanghai, 200072, China.
Ping LiDepartment of Respiratory Medicine, Shanghai 10th People's Hospital, Tongji University School of Medicine, #301, Mid Yanchang Rd, Shanghai, 200072, China.
Yang LiuDepartment of Respiratory Medicine, Shanghai 10th People's Hospital, Tongji University School of Medicine, #301, Mid Yanchang Rd, Shanghai, 200072, China.
Xiaofeng LiDepartment of Emergency, Shanghai 10th People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
Weiwei LiDepartment of Geriatrics, Shanghai 10th People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
Changhui WangDepartment of Respiratory Medicine, Shanghai 10th People's Hospital, Tongji University School of Medicine, #301, Mid Yanchang Rd, Shanghai, 200072, China. wang-chang-hui@hotmail.com.ORCID http://orcid.org/0000-0001-6118-6126
Shuanshuan XieDepartment of Respiratory Medicine, Shanghai 10th People's Hospital, Tongji University School of Medicine, #301, Mid Yanchang Rd, Shanghai, 200072, China. xieshuanshuan@aliyun.com.
Tongji University · CN

Funding

National Natural Science Foundation of China 81802262
6 · The paper itself

Abstract

backgroundAlthough traditional diagnostic techniques of infection are mature and price favorable at present, most of them are time-consuming and with a low positivity. Metagenomic next⁃generation sequencing (mNGS) was studied widely because of identification and typing of all pathogens not rely on culture and retrieving all DNA without bias. Based on this background, we aim to detect the difference between mNGS and traditional culture method, and to explore the relationship between mNGS results and the severity, prognosis of infectious patients.

methods109 adult patients were enrolled in our study in Shanghai Tenth People's Hospital from October 2018 to December 2019. The diagnostic results, negative predictive values, positive predictive values, false positive rate, false negative rate, pathogen and sample types were analyzed by using both traditional culture and mNGS methods. Then, the samples and clinical information of 93 patients in the infected group (ID) were collected. According to whether mNGS detected pathogens, the patients in ID group were divided into the positive group of 67 cases and the negative group of 26 cases. Peripheral blood leukocytes, C-reactive protein (CRP), procalcitonin (PCT) and neutrophil counts were measured, and the concentrations of IL-2, IL-4, IL-6, TNF-α, IL-17A, IL-10 and INF-γ in the serum were determined by ELISA. The correlation between the positive detection of pathogens by mNGS and the severity of illness, hospitalization days, and mortality were analyzed.

results109 samples were assigned into infected group (ID, 92/109, 84.4%), non-infected group (NID, 16/109, 14.7%), and unknown group (1/109, 0.9%). Blood was the most abundant type of samples with 37 cases, followed by bronchoalveolar lavage fluid in 36 cases, tissue, sputum, pleural effusion, cerebrospinal fluid (CSF), pus, bone marrow and nasal swab. In the ID group, the majority of patients were diagnosed with lower respiratory system infections (73/109, 67%), followed by bloodstream infections, pleural effusion and central nervous system infections. The sensitivity of mNGS was significantly higher than that of culture method (67.4% vs 23.6%; P < 0.001), especially in sample types of bronchoalveolar lavage fluid (P = 0.002), blood (P < 0.001) and sputum (P = 0.037), while the specificity of mNGS was not significantly different from culture method (68.8% vs 81.3%; P = 0.41). The number of hospitals stays and 28-day-motality in the positive mNGS group were significantly higher than those in the negative group, and the difference was statistically significant (P < 0.05). Age was significant in multivariate logistic analyses of positive results of mNGS.

conclusionsThe study found that mNGS had a higher sensitivity than the traditional method, especially in blood, bronchoalveolar lavage fluid and sputum samples. And positive mNGS group had a higher hospital stay, 28-day-mortality, which means the positive of pathogen nucleic acid sequences detection may be a potential high-risk factor for poor prognosis of adult patients and has significant clinical value. MNGS should be used more in early pathogen diagnosis in the future.

Indexed as

Severity of Illness IndexAdultAgedAged, 80 and overBlood CultureBronchoalveolar Lavage FluidChinaCommunicable DiseasesDiagnostic Tests, RoutineFemaleHigh-Throughput Nucleotide SequencingHumansLength of StayMaleMetagenomicsMiddle AgedDiagnosticInfectionNext-generation sequencingSensitivitySurvival

Identifiers

PMID33435894
PMCPMC7805029
OpenAlexW3113186381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.